SCHEMBL864064

SCHEMBL864064

NC(c1ccccn1)(c1ccccn1)c1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
PI4KA P42356 1/20 0.46
PI4K2B Q8TCG2 1/20 0.46
PI4K2A Q9BTU6 1/20 0.46
PI4KB Q9UBF8 1/20 0.46
KDM4E B2RXH2 6/20 0.43
LMNA P02545 3/20 0.43
CCR1 P32246 2/20 0.43
CCR5 P51681 2/20 0.43
CCR8 P51685 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
METAP1 P53582 1/20 0.43
BLM P54132 1/20 0.43
HIF1A Q16665 1/20 0.43
DOHH Q9BU89 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29017954 0.97 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL4370209 0.86 KCNN4 (0.54) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL5609255 0.86 KCNN4 (0.54) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL2435903 0.82 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL27615166 0.81 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL6348517 0.80 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL1921572 0.80 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL29435883 0.80 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL1114414 0.80 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1NOS3NOS1NOS2
SCHEMBL31036835 0.80 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023241033-A1 POLYMERIZATION METHOD MEDIATED AND INITIATED BY OXYGEN-RESISTANT AND BIOCOMPATIBLE METALLIC TIN AND USE THEREOF 中国科学院宁波材料技术与工程研究所 2023-12-21 WO claimed
CN-117015547-A Transition metal complexes containing tetradentate nitrogen donor ligands and electrochemical biosensors comprising the same 爱-森新株式会社 2023-11-07 CN claimed
CN-116640265-A Intrinsic stretchable room-temperature phosphorescent polymer material and preparation method thereof 西北工业大学 2023-08-25 CN claimed
WO-2024138228-A1 COMPOSITIONS, SYSTEMS AND METHODS FOR STEREOSELECTIVE MODIFICATION OF AROMATIC SUBSTRATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-06-27 WO disclosed
US-20240158426-A1 TRANSITION METAL COMPLEX CONTAINING TETRADENTATE NITROGEN DONOR LIGAND AND ELECTROCHEMICAL BIOSENSOR COMPRISING SAME I-SENS, INC. (KR) 2024-05-16 US disclosed
CN-117558789-A Photovoltaic backboard with high water vapor barrier and preparation method thereof 常州华科聚合物股份有限公司 2024-02-13 CN disclosed
WO-2023241033-A1 POLYMERIZATION METHOD MEDIATED AND INITIATED BY OXYGEN-RESISTANT AND BIOCOMPATIBLE METALLIC TIN AND USE THEREOF 中国科学院宁波材料技术与工程研究所 2023-12-21 WO disclosed
EP-4273152-A1 TRANSITION METAL COMPLEX CONTAINING TETRADENTATE NITROGEN DONOR LIGAND AND ELECTROCHEMICAL BIOSENSOR COMPRISING SAME I-SENS, INC. (KR) 2023-11-08 EP disclosed
CN-117015547-A Transition metal complexes containing tetradentate nitrogen donor ligands and electrochemical biosensors comprising the same 爱-森新株式会社 2023-11-07 CN disclosed
CN-116640265-A Intrinsic stretchable room-temperature phosphorescent polymer material and preparation method thereof 西北工业大学 2023-08-25 CN disclosed
CN-116272987-A Catalyst for catalyzing epoxidation reaction of long-chain alpha-olefin and preparation method thereof 中科合成油技术股份有限公司 2023-06-23 CN disclosed
WO-2012091965-A1 ELECTROCHEMICALLY MEDIATED ATOM TRANSFER RADICAL POLYMERIZATION CARNEGIE MELLON UNIVERSITY (US) 2012-07-05 WO disclosed
US-20120077967-A1 NOVEL TECHNETIUM AND RHENIUM COMPLEXES GE HEALTHCARE LIMITED (GB) 2012-03-29 US disclosed
EP-1799274-B1 NOVEL TECHNETIUM AND RHENIUM COMPLEXES, LIGANDS USED IN THEIR PREPARATION AND THEIR USE AS RADIOPHARMACEUTICALS GE HEALTHCARE LTD (GB) 2011-12-21 EP disclosed
US-8022211-B2 radiopharmaceuticals for SPECT imaging; kit comprises a biocompatible reductant; tripodal ligands GE HEALTHCARE LIMITED (GB) 2011-09-20 US disclosed
US-20080219921-A1 Novel Technetium and Rhenium Complexes. GE HEALTHCARE LIMITED (GB) 2008-09-11 US disclosed
US-20080170986-A1 Zeolite Including Oxygen-Activated Metal Complex And Gas Decomposition Agent NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2008-07-17 US disclosed
CN-101113155-A Antineoplastic active ferrum complex and method for preparing same UNIV JIANGSU (CN) 2008-01-30 CN disclosed
EP-1799274-A2 NOVEL TECHNETIUM AND RHENIUM COMPLEXES, LIGANDS USED IN THEIR PREPARATION AND THEIR USE AS RADIOPHARMACEUTICALS GE Healthcare Limited (GB) 2007-06-27 EP disclosed
WO-2006037988-A2 NOVEL TECHNETIUM AND RHENIUM COMPLEXES, LIGANDS USED IN THEIR PREPARATION AND THEIR USE AS RADIOPHARMACEUTICALS GE HEALTHCARE LIMITED (GB) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080219921-A1 Novel Technetium and Rhenium Complexes. IPO5, RAB35, TCOF1 SMN1; SMN2 4821/4885L3MBTL1 3738/4885NOS3 4549/4885
US-20120077967-A1 NOVEL TECHNETIUM AND RHENIUM COMPLEXES IPO5, RCN1, RAB35 SMN1; SMN2 4783/4885L3MBTL1 3286/4885NOS3 4622/4885
US-20240158426-A1 TRANSITION METAL COMPLEX CONTAINING TETRADENTATE NITROGEN DONOR LIGAND AND ELECTROCHEMICAL BIOSENSOR COMPRISING SAME NCS1, DNTT, SPR SMN1; SMN2 3938/4885L3MBTL1 3969/4885NOS3 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.